Previous Article | Next Article ![]()
Infection and Immunity, September 2002, p. 5058-5064, Vol. 70, No. 9
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.9.5058-5068.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
and S. Srikumaran1*
Department of Veterinary & Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583,1 Periparturient Diseases of Cattle Research Unit, National Animal Disease Center, USDA Agricultural Research Service, Ames, Iowa 500102
Received 25 January 2002/ Returned for modification 5 April 2002/ Accepted 8 June 2002
|
|
|---|
chains, CD11a, CD11b, and CD11c, to give rise to three different ß2 integrins, CD11a/CD18 (LFA-1), CD11b/CD18 (Mac-1), and CD11c/CD18 (CR4), respectively. Our earlier studies revealed that Lkt binds to all three ß2 integrins, suggesting that the common ß subunit, CD18, may be the receptor for Lkt. In order to unequivocally elucidate the role of bovine CD18 as a receptor for Lkt, a murine cell line nonsusceptible to Lkt (P815) was transfected with cDNA for bovine CD18. One of the transfectants, 2B2, stably expressed bovine CD18 on the cell surface. The 2B2 transfectant was effectively lysed by Lkt in a concentration-dependent manner, whereas the P815 parent cells were not. Immunoprecipitation of cell surface proteins of 2B2 with monoclonal antibodies specific for bovine CD18 or murine CD11a suggested that bovine CD18 was expressed on the cell surface of 2B2 as a heterodimer with murine CD11a. Expression of bovine CD18 and the Lkt-induced cytotoxicity of 2B2 cells were compared with those of bovine polymorphonuclear neutrophils and lymphocytes. There was a strong correlation between cell surface expression of bovine CD18 and percent cytotoxicity induced by Lkt. These results indicate that bovine CD18 is necessary and sufficient to mediate Lkt-induced cytolysis of target cells. |
|
|---|
Leukotoxin (Lkt) is a 102-kDa glycoprotein which is produced during the logarithmic phase of bacterial growth in vitro (2, 28). Lkt belongs to the family of RTX (repeats in toxins) toxins and shares extensive homology with the exotoxins produced by other gram-negative bacteria such as Escherichia coli (33), Actinobacillus pleuropneumoniae (8), and Actinobacillus actinomycetemcomitans (17). Despite the extensive homology shared by the RTX family, there is a marked dichotomy among the members of the family with respect to target cell specificity. The toxins secreted by E. coli and A. pleuropneumoniae are lytic to erythrocytes as well as a variety of nucleated cells including the leukocytes from different species (10, 16). In contrast, the toxins secreted by A. actinomycetemcomitans and M. haemolytica exhibit species and target cell specificity. Lkt secreted by A. actinomycetemcomitans is specific for primate leukocytes (30), while Lkt secreted by M. haemolytica is specific for ruminant leukocytes (5, 15, 27). Significant progress has been made towards identifying the receptor for the RTX toxins. Lally et al. (18) identified the ß2 integrin LFA-1 as the receptor for Lkt of A. actinomycetemcomitans and the
-hemolysin of E. coli. Subsequently, ß2 integrins have been identified as the receptors for Lkt of M. haemolytica (1, 13, 20, 37). ß2 integrins are leukocyte-specific integrins which have a common ß subunit, CD18, that associates with three distinct
chains, CD11a, CD11b, and CD11c, to give rise to three different ß2 integrins: CD11a/CD18 (LFA-1), CD11b/CD18 (Mac-1), and CD11c/CD18 (CR4), respectively. While there is agreement that ß2 integrins are the receptors for Lkt, there is no consensus on the subunit of the ß2 integrins that serve as the receptor for Lkt. Previous studies in our laboratory revealed that Lkt binds to all three ß2 integrins, suggesting that the ß subunit CD18, which is common to all three ß2 integrins, is the subunit that mediates Lkt-induced cytolysis of bovine leukocytes. One of the methods of unequivocal identification of bovine CD18 as a receptor for Lkt is to render Lkt-nonsusceptible cells susceptible to Lkt-induced lysis by recombinant expression of bovine CD18 in Lkt-nonsusceptible cells. Therefore, the objective of this study was to transfect an Lkt-nonsusceptible murine cell-line with cDNA for bovine CD18 and to determine the susceptibility of the transfectant to Lkt-induced cytolysis.
|
|
|---|
The monoclonal antibodies (MAbs) used in this study and their specificities are presented in Table 1.
|
View this table: [in a new window] |
TABLE 1. Description of the antibodies used in this study
|
Subcloning and expression of bovine CD18. The cloning, sequencing, and characterization of bovine CD18 has been described previously (29). In this study, the cDNA for bovine CD18 was released from pBluescript vector by using AccI (New England Biolabs, Beverly, Mass.). The resultant DNA fragment was subcloned into the AccI restriction site in the multiple cloning site of eukaryotic expression vector pCI-neo (Promega, Madison, Wis.) to yield the expression vector pMD-1 (Fig. 1). The correct orientation of the bovine CD18 gene in pMD-1 was confirmed by restriction digestion analysis with NotI, StuI, and XhoI (New England Biolabs). The sequence of the inserted DNA was further confirmed by sequencing pMD-1, using 5'-CGACTCACTATAGGGCGAAT-3' (T7 polymerase) and 5'-ATTAACCCTCACTAAAG-3' (T3 polymerase) forward and reverse primers, respectively. The sequencing was performed by the DNA Sequencing and Synthesis Facility at Iowa State University, Ames. P815 cells were transfected for stable expression of bovine CD18 with pMD-1, using SuperFect transfection reagent (Qiagen, Valencia, Calif.) according to the manufacturer's instructions. Briefly, 5 x 105 cells were incubated with 0.5 µg of pMD-1 and 2.5 µl of the transfection reagent. The cells were resuspended 48 h later in selection medium supplemented with Geneticin (500 µg/ml) and plated into 96-well plates. Two weeks posttransfection, clones that continued to grow in the selection medium were tested for cell surface expression of bovine CD18 molecules, using the anti-bovine CD18 MAb BAQ30A (Table 1), by flow cytometric analysis.
![]() View larger version (26K): [in a new window] |
FIG. 1. Schematic representation of the eukaryotic expression vector pMD-1 expressing bovine CD18. The cDNA for bovine CD18 was subcloned into the mammalian expression vector pCI-neo to yield pMD-1.
|
Flow cytometric analysis for the cell surface expression of bovine CD18. The transfectants, parent cells (P815), bovine PMNs, and bovine lymphocytes were tested for cell surface expression of bovine CD18, using anti-bovine CD18 MAbs (Table 1) in a flow cytometric analysis according to procedures described previously (24). Briefly, 5 x 105 P815 cells, transfectant, bovine PMNs, or lymphocytes were incubated with 50 µl of BAQ30A MAb at 4°C for 1 h. Following three washes in FACS buffer (3% horse serum and 0.01% sodium azide in PBS), the cells were incubated with 50 µl of fluorescein isothiocyanate-labeled goat antibodies specific for mouse Ig (KPL, Gaithersburg, Md.) at 4°C for 30 min. The cells were washed three times with FACS buffer, resuspended, and analyzed by a flow cytometer (Becton-Dickenson, La Jolla, Calif.).
MTT assay for Lkt-induced cytotoxicity and Lkt neutralization. The susceptibility of the different cell types to M. haemolytica Lkt-mediated cytolysis was determined by a previously described cytotoxicity assay {MTT [3-(4,5-dimethylthiazoyl-2-Yl)-2,5-diphenyl tetrazolium bromide; Sigma] dye reduction assay} (1). This assay measures the ability of the endoplasmic reticulum-resident enzymes in viable cells to convert a tetrazolium dye into a purple formazan precipitate, which is later dissolved in acid isopropanol. The optical density (OD) of the end product, representing the intensity of the purple color which developed, is directly proportional to the viability of the cells. Briefly, the cells were resuspended in colorless RPMI 1640 medium (RPMI 1640 medium without neutral red) at a concentration of 1 x 107/ml and seeded into 96-well round-bottomed microtiter plates in duplicates (50 µl per well). Fifty microliters of serially diluted Lkt in colorless RPMI 1640 medium was added into each well, and the plates were incubated at 37°C for 1 h. The cells were centrifuged at 600 x g for 5 min following incubation, and the supernatant fluid was discarded. The cells were resuspended in 100 µl of colorless RPMI 1640 medium, and 20 µl of 0.5% MTT was added to each well. Following incubation at 37°C for 2 h, the cells were centrifuged at 600 x g for 5 min and the supernatant fluid was discarded. The remaining formazan precipitate was thoroughly dissolved in 100 µl of acid isopropanol, and the OD of the samples was measured using an enzyme-linked immunosorbent assay reader. The percent cytotoxicity was calculated as follows: % cytotoxicity = [1 - (OD of toxin-treated cells/OD of toxin-untreated cells)] x 100.
For Lkt neutralization, 50 µl of toxin preparation at a 50% toxicity end point titer of 4 was incubated with 50 µl of Lkt-neutralizing MAb MM601 culture supernatant at 4°C for 30 min, followed by incubation at room temperature for 30 min. 2B2 cells (5 x 105 cells) were added, and the MTT assay was performed as described above. The anti-BHV-1 glycoprotein D MAb MM113 (Table 1) was used as a negative control for neutralization. The percent cytotoxicity was calculated as described above.
Cytotoxicity inhibition assay using anti-bovine CD18 MAb. The inhibition of cytotoxicity assay was performed using anti-bovine CD18 MAbs as described previously (1). Briefly, 2B2 cells (5 x 105 cells) were incubated with anti-bovine CD18 MAbs BAQ30A and H20A (Table 1) or control MAbs MM113 and 9D6 (Table 1); the final concentration of each MAb was 100 µg/ml. After 1.5 h of incubation at 4°C, the cells were washed and the MTT assay was performed as described above. The percent inhibition of cytotoxicity was calculated using the formula: percent inhibition of cytotoxicity = [(percent cytotoxicity in the absence of antibodies - percent cytotoxicity in the presence of antibodies)/percent cytotoxicity in the absence of antibodies] x 100.
Radiolabeling of cell surface molecules with 125I. The cell surface proteins of P815 and 2B2 cells were labeled with 125I (Perkin-Elmer Life Sciences, Boston, Mass.), using the lactoperoxidase method as described previously (34). Briefly, 5 x 107 cells were washed three times in cold PBS and resuspended in 1 ml of 20 mM glucose (Sigma) in PBS (pH 7.4). Ten microliters of 100 mCi of Na125I/ml, 30 µl of lactoperoxidase solution (0.5 mg/ml in distilled water; Sigma), and 10 µl of glucose oxidase (1,000 U of stock solution/ml in water diluted 1:400 in PBS immediately before use; Sigma) were added in succession to the cell suspension, and the mixture was incubated for 10 min on ice with gentle mixing. The labeled cells were washed three times with PBS to remove unconjugated 125I. The radiolabeled cells were incubated with 2.5 ml of lysis buffer (0.5% CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate}, 10 mM Tris, 151 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 1x protease inhibitor cocktail P-8340; all from Sigma) for 30 min at 4°C. The lysate was centrifuged at 15,000 x g for 10 min in a microcentrifuge, and the supernatant fluid was passed through a PD-10 column (Sephadex G25; Amersham Pharmacia Biotech) overlaid with anion exchange resin AG1X8 (Bio-Rad, Hercules, Calif.) to remove unbound 125I. The fall-through fractions were collected, and the radioactivity levels were determined. The fractions with high radioactivity were pooled and used for immunoprecipitation.
Immunoprecipitation of bovine CD18 and mouse CD11a. The radiolabeled cell lysates (750 µl) were precleared overnight on a shaker at 4°C with 20 µl (500 µg/ml) of affinity-purified isotype-matched control 9D6 MAb and protein G Sepharose (Amersham Pharmacia Biotech). The protein G Sepharose beads were removed by centrifugation at 15,000 x g for 5 min in a microcentrifuge. Immunoprecipitation was performed by incubating 750 µl of precleared cell lysate with either 20 µl (500 µg/ml) of anti-murine CD11a MAb (2D7), anti-bovine CD18 MAb (BAQ30A), or isotype-matched control 9D6 MAb. Following incubation at 4°C for 2 h, the immune complexes were captured using protein G Sepharose beads by incubation for 2 h. The protein G Sepharose beads were washed three times with washing buffer (0.1% CHAPS, 10 mM Tris, 151 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 1x protease inhibitor cocktail P-8340; Sigma), and the immune complexes were eluted by boiling the beads at 95°C for 5 min in reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer. The precipitated proteins were separated by SDS-PAGE, and the gel was dried and subjected to autoradiography.
Statistical analyses. Statistical analyses were performed using Statistical Analysis Software (SAS Institute Inc., Cary, N.C.). Pearson's correlation significance (two-tailed) test was used to determine the correlation between the degree of Lkt-induced cytolysis and cell surface expression of CD18.
|
|
|---|
![]() View larger version (25K): [in a new window] |
FIG. 2. Cell surface expression of bovine CD18 on P815 cells transfected with bovine CD18. The transfectant expressing bovine CD18 (2B2) and the parent cells (P815) were tested for the cell surface expression of bovine CD18 by flow cytometric analysis using an anti-bovine CD18 BAQ30A MAb. Anti-BHV-1 gD MAb 9D6 (Table 1) was used as an isotype-matched control antibody in the assay. Results of one representative experiment out of three are shown.
|
and ß subunits (11). It has been documented that the
subunit (CD11) and the ß subunit (CD18) have to associate with each other to be transported to the plasma membrane and expressed on the cell surface (22). Therefore, it was of interest for us to determine whether the bovine CD18 was expressed as a heterodimer with murine CD11a. Lysates of P815 or 2B2 cells labeled with 125I were immunoprecipitated using MAb specific for bovine CD18 or murine CD11a. Anti-bovine CD18 MAb coprecipitated a protein with an apparent molecular size of 178 kDa (within the anticipated range for murine CD11a) along with a protein with an apparent molecular size of 100 kDa (within the anticipated range for bovine CD18) from 2B2 cells but not from P815 cells (Fig. 3). Anti-murine MAb CD11a, as expected, precipitated two proteins with apparent molecular sizes of 178 kDa and 100 kDa from both P815 and 2B2 cells (suggestive of mouse CD11a and mouse CD18 from P815 cells and mouse CD11a and mouse and/or bovine CD18 from 2B2 cells, respectively). Isotype-matched control antibody 9D6 did not precipitate any protein(s) from either P815 or 2B2 cells. These results suggest that bovine CD18 is expressed as a heterodimer with murine CD11a on the surface of 2B2 cells.
![]() View larger version (36K): [in a new window] |
FIG. 3. Bovine CD18 is expressed as a heterodimer with murine CD11a on the surface of bovine CD18 transfectant. 125I-labeled cell surface proteins of transfectant expressing bovine CD18 (2B2) and the parent cells (P815) were subjected to immunoprecipitation with either an anti-bovine CD18 MAb (BAQ30A), anti-murine CD11a MAb (2D7), or an isotype-matched control MAb (9D6). The immunoprecipitated proteins were subjected to SDS-PAGE followed by autoradiography. Lane 1: 14C-molecular weight marker. Lanes 2, 3, and 4 represent 2B2 lysate immunoprecipitated with isotype-matched control MAb, anti-murine CD11a MAb, and anti-bovine CD18 MAb, respectively. Lanes 5, 6, and 7 represent P815 lysate immunoprecipitated with control, anti-murine CD11a, and anti-bovine CD18 MAbs, respectively. Results of one representative experiment out of three are shown.
|
![]() View larger version (20K): [in a new window] |
FIG. 4. Lkt lyses bovine CD18 transfectant, but not the parent cells. The transfectant expressing bovine CD18 (2B2), the parent cells (P815), and three murine cell lines of leukocytic origin (A20, a B-cell line; BW5147, a T-cell line; and EL4, a thymoma cell line) were subjected to a MTT dye reduction cytotoxicity assay with a 1:16 dilution of Lkt. The percent cytotoxicity was calculated as follows: percent cytotoxicity = [1 - (OD of toxin-treated cells/OD of toxin-untreated cells)] x 100. Results shown are the means of three independent experiments. The error bars indicate standard deviations of the means.
|
![]() View larger version (24K): [in a new window] |
FIG. 5. Lkt lyses P815 cells transfected with bovine CD18 in a concentration-dependent manner. The parent cells (P815) and the transfectant expressing bovine CD18 (2B2) were subjected to a MTT dye reduction cytotoxicity assay with twofold dilutions of Lkt. The percent cytotoxicity was calculated as for Fig. 4. Results shown are the means of three independent experiments. The error bars indicate standard deviations of the means.
|
![]() View larger version (32K): [in a new window] |
FIG. 6. Anti-bovine CD18 MAbs inhibit Lkt-induced cytolysis of transfectant expressing bovine CD18. Lkt was added to the transfectant expressing bovine CD18 (2B2) that was preincubated with MAbs BAQ30A and H20A or MM113 and 9D6. The viability of the cells was determined by a MTT dye reduction cytotoxicity assay. The percent inhibition of cytotoxicity was calculated as follows: percent inhibition of cytotoxicity = [(percent cytotoxicity in the absence of antibodies - percent cytotoxicity in the presence of antibodies)/percent cytotoxicity in the absence of antibodies] x 100. Results shown are the means of three independent experiments. The error bars indicate standard deviations of the means.
|
![]() View larger version (32K): [in a new window] |
FIG. 7. Anti-Lkt neutralizing MAb abolishes Lkt-mediated killing of transfectants expressing bovine CD18. Lkt was incubated with either the neutralizing MAb MM601 or a control MM-113 MAb, and the ability of Lkt to lyse the transfectant expressing bovine CD18 (2B2) was tested in an MTT assay. The percent cytotoxicity was calculated as for Fig. 4. Results shown are the means of three independent experiments. The error bars indicate standard deviations of the means.
|
![]() View larger version (42K): [in a new window] |
FIG. 8. Cytolysis of bovine PMNs, lymphocytes, and murine transfectant expressing bovine CD18. Lkt-induced cytolysis of bovine CD18 transfectant (2B2), bovine PMNs, and lymphocytes was measured by an MTT dye reduction cytotoxicity assay. The percent cytotoxicity was calculated as for Fig. 4. Results shown are the means of three independent experiments. The error bars indicate standard deviations of the means.
|
![]() View larger version (29K): [in a new window] |
FIG. 9. Expression of bovine CD18 by the murine transfectant expressing bovine CD18, bovine PMNs, and lymphocytes. The transfectant (2B2), parent cell line (P815), bovine PMNs, and lymphocytes were analyzed for the degree of cell surface expression of bovine CD18, using an anti-bovine CD18 MAb, by flow cytometry. Results of one representative experiment out of three are shown.
|
|
|
|---|
subunits (CD11a, CD11b, and CD11c) and the ß subunit (CD18) of ß2 integrins. These results suggested that the CD18 subunit brought down all three
subunits along with it when the cell lysate was passed through a Lkt prebound column. In addition, in a cytotoxicity inhibition assay, an anti-CD18 MAb reduced Lkt-induced cytotoxicity of bovine PMNs by more than 50%. Taken together, these results indicated that Lkt binds to the ß2 integrins, most likely via CD18 (1). However, a later study by Jeyaseelan et al. (13), based on Western blot analysis of proteins eluted from Lkt beads and blocking experiments with integrin subunit-specific MAbs, concluded that Lkt binds to CD11a and not to CD18. Therefore, our study was designed to resolve the discrepancy on the role of bovine CD18 in Lkt-induced cytolysis as reported in the literature. We reasoned that recombinant expression of bovine CD18 on Lkt-nonsusceptible cells and examination of their susceptibility to Lkt-induced cytolysis would unequivocally determine the role of bovine CD18 in Lkt-induced cytolysis. We chose to examine Lkt-induced lysis of the cells rather than the binding of Lkt to the cells, since binding of Lkt to bovine leukocytes is not specific. It has been demonstrated that Lkt also binds to nonruminant leukocytes (13) without eliciting any effects.
Transfection of the murine mastocytoma cell line P815, which is not susceptible to Lkt-induced cytolysis, resulted in a stable transfectant, 2B2, that expressed bovine CD18 on the cell surface (Fig. 2). It is a well-established fact that the
subunit (CD11) and the ß subunit (CD18) have to associate with each other in order to be transported to the plasma membrane and expressed on the cell surface (22). Hence, it is very likely that the transfected bovine CD18 molecule is expressed on the surface of 2B2 cells as a heterodimer with the murine CD11a molecules of the P815 parent cells (CD11b and CD11c molecules are not expressed on P815 cells; data not shown). Coprecipitation of a 178-kDa protein (likely to be murine CD11a), along with the 100-kDa bovine CD18 from 125I-labeled 2B2 cell surface proteins by the anti-bovine CD18 MAb, supports this hypothesis (Fig. 3).
The 2B2 cells, but not the parent cells, were lysed by Lkt (Fig. 4). Three other murine cell lines of leukocytic origin were not lysed by Lkt above the background levels routinely observed by us in cytotoxicity assays with some cell types. Furthermore, in a cytotoxicity assay with different concentrations of Lkt, the 2B2 cells were lysed by Lkt in a concentration-dependent manner (Fig. 5). Taken together, these results indicate that the susceptibility of the 2B2 cells to Lkt-induced lysis is mediated by bovine CD18 molecules expressed on the surface of 2B2 cells. The reason that the percent cytotoxicity of 2B2 cells in the cytotoxicity assay in Fig. 5 was lower than that in the cytotoxicity assay in Fig. 4 was that the assay in Fig. 5 was conducted at a later time and with a different clone of the 2B2 cells that expressed lower levels of bovine CD18.
Preincubation of 2B2 cells with anti-bovine CD18 MAbs partially inhibited the cytolysis of these cells (Fig. 6). Lack of complete inhibition of Lkt-induced cytolysis by these MAbs could be explainable if these MAbs do not bind to the same site on the CD18 molecule as Lkt does. Partial inhibition of Lkt-induced cytolysis by anti-bovine CD18 MAbs have been reported by other workers also (13, 20). Preincubation of Lkt with an Lkt-neutralizing MAb, MM601, abolished the lysis of 2B2 cells, indicating the specificity of lysis (Fig. 7). Next, we compared Lkt-induced cytolysis of 2B2 cells with that of bovine PMNs and lymphocytes (Fig. 8). Cytolysis levels of 2B2 cells were comparable to those of bovine lymphocytes but lower than those of PMNs. This result is to be expected, since PMNs express all three ß2 integrins (LFA-1, Mac-1, and CR4), while the majority of lymphocytes express only LFA-1 (11). 2B2 cells express a chimeric LFA-1 (murine CD11a/bovine CD18) only, because the parent P815 cells do not express CD11b or CD11c. Thus, the amount of bovine CD18 expressed on PMNs is much greater than that expressed on bovine lymphocytes and 2B2 cells. This differential expression is very likely to be responsible for the higher level of cytolysis of PMNs by Lkt. In order to test this hypothesis, we measured cell surface expression of bovine CD18 on PMNs, lymphocytes, and 2B2 cells by flow cytometric analysis with a MAb specific for bovine CD18. There was a strong correlation between the degree of cell surface expression of bovine CD18 and the degree of cytolysis of PMNs, lymphocytes, and 2B2 cells. This correlation was statistically significant (r = 0.99). In other words, the higher the cell surface expression of bovine CD18, the higher the degree of cytolysis. Taken together, these results clearly indicate that Lkt-induced cytolysis is mediated by bovine CD18.
Comparison of the amino acid sequence of bovine CD18 with those of murine and human CD18 reveals 86 and 87% sequence homology, respectively. Thus, it is conceivable that the binding site(s) of Lkt on bovine CD18 resides outside these regions of homology and that the specificity of Lkt to ruminant leukocytes is dictated by the domains formed by the remaining 15% of nonhomologous regions on bovine CD18.
The inhibition of binding of Lkt to, and lysis of, bovine PMNs by an anti-bovine CD11a MAb observed by Jeyaseelan et al. (13) could be due to physical obstruction to the Lkt binding of CD18 by binding of the anti-CD11a MAb to CD11a. Several examples of inhibition of binding of a ligand to its receptor by a MAb binding to a closely juxtaposed molecule have been reported in the literature (21, 23, 25, 36). Our finding that bovine CD18 mediates Lkt-induced lysis is further supported by a recent study from the same laboratory (14). This study, which examined the activation of signaling pathways following Lkt binding of bovine leukocytes, concluded that Lkt induces tyrosine phosphorylation of the CD18 tail of LFA-1 in bovine leukocytes.
In summary, inhibition of Lkt-mediated apoptosis studies of Wang et al. (37), ligand blotting studies of Li et al. (20), and Lkt affinity chromatography and immunochemical characterization studies from our laboratory (1) indicated that bovine CD18 is the subunit of ß2 integrins that interacts with Lkt of M. haemolytica. In this study, by rendering Lkt-nonsusceptible murine cells susceptible to lysis by Lkt by recombinant expression of bovine CD18, we have clearly demonstrated in a biologically relevant system that bovine CD18 is necessary and sufficient for Lkt-induced lysis of target cells. However, the CD11 molecule may play a role in stabilization of the proper conformation of the CD18 molecule on the cell surface.
This article is published as ARD Journal Series no. 13606, with the approval of the University of Nebraska Agricultural Research Division. ![]()
Present address: Pfizer Global Research and Development, Veterinary Medicine Pharmaceutical Discovery, Terre Haute, IN 47808. ![]()
|
|
|---|
3 inhibits
1-mediated hemagglutination by steric hindrance. J. Virol. 75:6625-6634.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»